Tempus AI
AI-enabled precision medicine platform using clinical and molecular data to improve patient outcomes.
About
Tempus is an AI-powered precision medicine company that analyzes clinical and molecular data to accelerate research and improve patient care. Its platform offers genomic testing, AI-enabled algorithms, and real-world data solutions to support providers in making informed treatment decisions, life sciences companies in drug development, and patients in accessing clinical trials. Tempus serves physicians, researchers, life sciences organizations, and patients across oncology, neurology, psychiatry, cardiology, and radiology. Teams look it up for AI, Healthcare, Biotech.
Frequently asked
What does Tempus AI do?
Tempus AI is an AI company that offers Platform. Teams look it up for Healthcare, Biotech, Precision Medicine. It is based in Chicago, United States and was founded in 2015. Public records show $380M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Tempus AI raised?
Tempus AI has raised a total of $380M in funding. The most recent round on record is Series F.
Where is Tempus AI headquartered?
Tempus AI is headquartered in Chicago, United States.
When was Tempus AI founded?
Tempus AI was founded in 2015.
What industry does Tempus AI operate in?
Tempus AI operates in AI, Healthcare, Biotech, Precision Medicine.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
